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Trichophyton rubrum (T. rubrum) is the most common 
cause of superficial dermatomycoses worldwide and 
is responsible for more than 70% of all dermatophyte 
infections (1). T. rubrum infections can be long-lasting, 
difficult to treat and commonly recur after cessation 
of antifungal therapy (2). Unsuccessful treatment may 
be due to re-infection and poor adherence. Recurrence 
is seldom thought to be associated with resistance to 
antifungal agents and only a few cases of T. rubrum re-
sistance to terbinafine have been reported (3). We report 
here a case of a patient with severe worsening of Darier 
disease (DD) due to widespread cutaneous terbinafine-
resistant T. rubrum infection. 
CASE REPORT
A 62-year-old man with DD was referred for evaluation 
due to a flare-up of his skin condition. The patient had 
experienced skin changes of fluctuating severity since the 
age of 12 years. His father was also known to have DD. 
Over the years he had consulted several dermatologists 
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and been prescribed various topical agents and systemic 
acitretin, with little or no effect. In addition, he underwent 
numerous topical and systemic treatments for flare-ups 
due to recurrent fungal, bacterial and viral skin infections.
At initial presentation to our clinic, besides usual 
keratotic follicular papules, several well-defined eryt-
hematous annular scaly plaques were observed on the 
trunk and extremities (Fig. 1), indicating tinea corporis, 
although the patient had recently taken oral terbinafine 
for months. 
Skin scraping was performed and direct microscopy 
revealed septate hyphae and arthroconidia. Culture on 
Sabouraud agar supplemented with cycloheximide, and 
direct PCR were positive for T. rubrum, as described 
previously (4). A skin biopsy, in addition to acantholysis 
typical of DD (Fig. 2a) showed fungal spores and hyphae 
within the stratum corneum (Fig. 2b). Over the course 
of the next 4 months treatment with topical antifungal, 
2 × 30-day courses of oral terbinafine (250 mg daily) 
and various topical corticosteroids failed to improve the 
patient’s skin condition. 
Due to the continued presentation of 
tinea corporis, fungal analyses were re-
peated and supplemented with antifungal 
susceptibility testing according to the 
European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) micro-
dilution reference method E.Def 9.3 with 
C. krusei ATCC6258 as control strain 
(5). This revealed the T. rubrum isolate 
to be resistant to terbinafine (minimum 
inhibitory concentration (MIC) > 4 µg/
ml), but susceptible to itraconazole (MIC 
0.03 µg/ml). A randomly selected clinical 
T. rubrum isolate was found sensitive to 
both drugs (terbinafine MIC: 0.25 µg/
ml, and itraconazole MIC ≤ 0.03 µg/
ml). Two weeks after treatment with oral 
itraconazole (100 mg twice daily) the 
patient showed a dramatic improvement, 
the round skin lesions had cleared and his 
DD settled (see Fig. 1).
DISCUSSION
DD is a rare genodermatosis characteri-
zed by persistent, greasy, hyperkeratotic 
Fig. 1. Clinical presentation. At admission (top panel) and 2 weeks after itraconazole 
treatment (bottom panel).
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papules in seborrhoeic areas of the face, scalp and 
chest. These papules may coalesce and form larger 
warty malodorous lesions, especially within skin folds. 
Pruritus and nail changes are also a common symptom. 
The onset of symptoms usually occurs in adolescence 
and may be exacerbated by heat, ultraviolet B (UVB) 
light and mechanical trauma. Flares of DD may also be 
brought on by secondary skin infections (6). Although 
there are only a few reports, it is generally thought that 
patients have a predisposition to secondary bacterial, 
viral and fungal infections, due to compromised skin 
integrity (7, 8). 
The case reported here illustrates a patient with severe 
DD complicated by T. rubrum infection, refractory to 
treatment until the dermatophyte infection was cleared. 
Terbinafine is often the antimycotic agent of choice when 
treating dermatophytes (9). It is a synthetic allyl amine 
derivative that inhibits squalene epoxidase, blocking the 
biosynthesis of ergosterol (an essential component of 
fungal cell membranes) and resulting in the accumulation 
of toxic levels of squalene (2, 3, 9).
Drug resistance in dermatophytes is rare and, to our 
knowledge, only one case of terbinafine-resistant T. 
rubrum has been published (9). In the literature the pro-
posed mechanism of acquired resistance is modification 
of the target enzyme by gene mutation and an increase 
in drug efflux; less frequently, intrinsic characteristics 
of a T. rubrum strain may play a role (2, 3). In our case 
it was more likely acquired as a result of prolonged 
terbinafine therapy.
With an increasing incidence of dermatophytosis, it 
is important to consider antifungal drug resistance as a 
cause of treatment failure.
The authors declare no conflicts of interest.
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Fig. 2. Cross-section of skin stained respectively with haematoxylin-eosin and periodic acid–Schiff. (A) 
acantholysis, and (B) presence of hyphae and spores between upper layer of basket-weave stratum corneum and 
lower layer of compact stratum corneum (sandwich sign).
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